Siemens Healthineers unveils MAMMOMAT B.brilliant, a revolutionary mammography system in Indonesia
SURABAYA, Indonesia, May 2, 2025 /PRNewswire/ -- Breast cancer remains one of the leading health concerns in Indonesia and ranks as the third deadliest cancer after lung and liver cancer. According to the Global Cancer Observatory, breast cancer accounts for 66,271 new cases (16.2%) out of a total of 408,661 new cancer...
How latest genetic data on fertility may be an indicator of chronic disease onset and longevity
SINGAPORE, May 2, 2025 /PRNewswire/ -- Latest population studies have cast new light on genetic influences on women's reproductive lifespans and possible markers for the onset of chronic diseases. Evidence is growing that conditions such as cardiovascular disease, type 2 diabetes, rheumatoid arthritis and neurodegenerative disorders are associated with reduced ovarian...
AROA hits evidence milestone with real-world study validating the efficacy of Endoform in treating challenging venous leg ulcers.
AUCKLAND, New Zealand, May 2, 2025 /PRNewswire/ -- Soft tissue regeneration company, Aroa Biosurgery, is pleased to announce a milestone in clinical evidence. There are now over 100 peer-reviewed studies describing the efficacy of the company's proprietary AROA ECM technology. AROA's most recent publication was a large retrospective analysis of real-world evidence (RWE)...
HistoIndex Secures SGD9 Million Investment to Drive Next Phase of Expansion
SINGAPORE, May 2, 2025 /PRNewswire/ -- HistoIndex, known for its groundbreaking biophotonic Second Harmonic Generation (SHG) technology and a pioneering leader in Artificial Intelligence (AI) digital pathology for the management of fibrotic diseases, has announced the close of a S$9 million investment round to support its next phase of expansion. OCBC, the longest established bank in Singapore...
Fertility experts urge the creation of registries to safeguard donor conception practices
SINGAPORE, May 2, 2025 /PRNewswire/ -- Gamete donation has accelerated around the world in the past decade driven in part by the emergence of commercial sperm and egg banks and a growing recognition of the validity of this form of family building among single women in some countries. However, lack of...
VISTA Eye Specialist Celebrates Breakthrough PX Ninety Collaboration with Shareef Mahdavi—Now Featured in Leading U.S. Medical Journal
PETALING JAYA, Malaysia, May 2, 2025 /PRNewswire/ -- Just months after announcing its dynamic partnership with world-renowned patient experience expert Shareef Mahdavi and the PX Ninety program, VISTA Eye Specialist is thrilled to mark a major milestone: the story of its PX Ninety and Ikigai WowX transformation has been published in the prestigious April edition of Cataract & Refractive...
FaceHeart Received Another FDA Clearance for its Contactless Video-Based Vital Sign Measurement of Respiratory Rate
Developed by FaceHeart, FH Vitals SDK-RR has obtained FDA Clearance. This is the second 510(k) class II SaMD (Software as a Medical Device) FaceHeart received from the FDA. FaceHeart Vitals™ is a video-based, contactless vital sign measurement SDK that can be integrated into devices such as smartphones seamlessly, providing heart rate, respiration rate, blood pressure and other...
No-Drama Modern Parenting: GROWNSY Shares 10 Must-Have Upgrades for Modern Moms This Mother’s Day
Because modern moms don't need clichés, they need real solutions. NEW YORK, May 1, 2025 /PRNewswire/ -- Today's parents are more informed, more intentional and frankly, more exhausted than ever before. And while the world keeps telling them to "enjoy every moment," GROWNSY is here to offer something far more useful: practical tools that actually help. ...
A global study led by CUHK and the University of Calgary charts four-stage evolution of Inflammatory Bowel Disease
HONG KONG, May 1, 2025 /PRNewswire/ -- An international consortium led by The Chinese University of Hong Kong (CUHK)'s Faculty of Medicine (CU Medicine) and the University of Calgary in Canada has conducted a global epidemiological study on Inflammatory Bowel Disease (IBD). It found that this chronic gut condition follows a four-stage epidemiological evolution across different regions of the world. Analysing...
A Pivotal Phase II/III Clinical Study of Anti-HER2 Bispecific Antibody KN026 Have Met the Primary Endpoint of PFS at Interim Analysis
SUZHOU, China, May 1, 2025 /PRNewswire/ -- Alphamab Oncology (stock code: 9966.HK) and CSPC Pharmaceutical Group Co., Ltd. ("CSPC") (Stock Code: 1093.HK) jointly announced that a phase II/III clinical trial of anti-HER2 bispecific antibody KN026 (Study ID: KN026-001) in combination with chemotherapy as second-line or above treatment of HER2-positive gastric cancer (GC) (including gastroesophageal junction cancer (GEJ)), has...
